IG Live September 27: Court Adjourned, Healthcare Overturned

Recent Supreme Court rulings are poised to significantly affect healthcare in the U.S.

In Loper Bright Enterprises v. Raimondo, the court overturned the Chevron doctrine, curbing the authority of federal agencies like the FDA and CMS. This shift could delay regulatory decisions on drug approvals, Medicare pricing, and nursing home oversight, as courts will no longer automatically defer to agency expertise.

In Moyle v. United States and Idaho v. United States, the court ruled that Idaho hospitals must continue providing emergency abortions if the mother’s life is at risk, but it stopped short of broader rulings on abortion rights. Similarly, in FDA v. the Alliance for Hippocratic Medicine, the court preserved access to the abortion pill mifepristone (Mifeprex) on the basis that the doctors who brought the case didn’t actually have the right to sue, known as “standing.”

Legal experts warned that these decisions were not true wins for reproductive rights: “Neither case settled the crucial issue of healthcare access presented by medication abortions and emergency medical care.”

Join us for an upcoming Instagram Live where experts will discuss the evolving legal landscape shaping healthcare access.

Featuring:

Jeremy Faust, MD, (moderator) editor-in-chief at MedPage Today (@jeremysamuelfaust)

Lawrence O. Gostin, JD, distinguished university professor at Georgetown University, co-faculty director at the O’Neill Institute, and director of the World Health Organization Collaborating Center on National & Global Health Law (@oneillinstitute)

How do I join? Follow @medpage on Instagram!

When is the event? Tune in Friday, September 27 at 2 p.m. ET

Can I submit questions? Yes, we encourage questions! Submit your questions prior to the event by commenting below.

Related articles:

Supreme Court Decision May Have Sweeping Effects on Healthcare, Experts Say

Docs Unmoved by Supreme Court’s Emergency Abortion Decision

The Supreme Court Did Not Deliver ‘Wins’ for Reproductive Rights This Term

On the Health Docket for the Supreme Court’s 2024 Term

Medical Groups Disappointed in SCOTUS Ruling on Affirmative Action

With the End of Chevron, Health and Environmental Experts’ Hands Are Tied

Supreme Court Will Take Up State Bans on Gender Care for Minors: Here’s What to Know

Supreme Court to Weigh If FDA Was Heavy-Handed With Its Flavored E-Cig Regulations

Supreme Court Preserves Access to Abortion Pill

SCOTUS Allows Emergency Abortions to Continue in Idaho, for Now

Even in the Wake of the Rahimi Case, Domestic Violence Still Threatens Our Patients

Please enable JavaScript to view the comments powered by Disqus.